BJDX
Bluejay Diagnostics Inc
NASDAQ: BJDX · HEALTHCARE · MEDICAL DEVICES
$1.88
+4.44% today
Updated 2026-04-30
Market cap
$1.96M
P/E ratio
—
P/S ratio
54.99x
EPS (TTM)
$-15.25
Dividend yield
—
52W range
$2 – $17
Volume
0.2M
Bluejay Diagnostics Inc (BJDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-117.00%
ROA
-62.80%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-757716.00 | — | — | — |
| 2020 | $0.00 | $-1.13M | — | — | — |
| 2021 | $75.00 | $-3.73M | -194,292.00% | -4,306,884.00% | -4,972,914.67% |
| 2022 | $249040.00 | $-9.30M | 19.64% | -3,741.48% | -3,733.11% |
| 2023 | $0.00 | $-9.95M | — | — | — |
| 2024 | $0.00 | $-7.72M | — | — | — |
| 2025 | $0.00 | $-6.85M | — | — | — |